AstraZeneca hits snag in COVID-19 drug development

Spread the love

LONDON: Vaccine-maker AstraZeneca on Tuesday (Jun 15) revealed it had hit a setback in trials of a treatment for the coronavirus.

The drug, made from a combination of two antibodies, failed its main goal to treat COVID-19 symptoms in exposed patients, AstraZeneca said in a statement.

The …

Related Posts